VA Awards $40.8M for QuidelOrtho Triage MeterPro Reagents and Supplies
Contract Overview
Contract Amount: $40,792 ($40.8K)
Contractor: Quidelortho Sales Company, LLC
Awarding Agency: Department of Veterans Affairs
Start Date: 2025-02-13
End Date: 2026-02-12
Contract Duration: 364 days
Daily Burn Rate: $112/day
Competition Type: COMPETED UNDER SAP
Number of Offers Received: 6
Pricing Type: FIRM FIXED PRICE
Sector: Healthcare
Official Description: QUIDELORTHRO TRIAGE METERPRO REAGENTS AND SUPPLIES
Place of Performance
Location: ALBUQUERQUE, BERNALILLO County, NEW MEXICO, 87108
Plain-Language Summary
Department of Veterans Affairs obligated $40,791.96 to QUIDELORTHO SALES COMPANY, LLC for work described as: QUIDELORTHRO TRIAGE METERPRO REAGENTS AND SUPPLIES Key points: 1. Contract awarded to QuidelOrtho Sales Company, LLC for essential medical supplies. 2. Competition method was 'COMPETED UNDER SAP', indicating a potentially competitive process. 3. Risk is moderate due to reliance on a single supplier for critical reagents. 4. Sector is Healthcare, specifically In-Vitro Diagnostic Substance Manufacturing.
Value Assessment
Rating: good
The contract value of $40.8M over one year appears reasonable for specialized diagnostic reagents. Benchmarking against similar contracts for in-vitro diagnostic supplies would provide further clarity on pricing efficiency.
Cost Per Unit: N/A
Competition Analysis
Competition Level: full-and-open
The contract was competed under SAP (Simplified Acquisition Procedures), suggesting a competitive process was utilized. This method aims to achieve fair and reasonable pricing through market research and competition among qualified vendors.
Taxpayer Impact: Taxpayers benefit from a competed contract, which generally leads to more competitive pricing and efficient use of funds for essential healthcare supplies.
Public Impact
Ensures availability of critical diagnostic reagents for VA healthcare facilities. Supports patient care by providing necessary tools for medical testing. Contributes to the supply chain for in-vitro diagnostics within the federal government.
Waste & Efficiency Indicators
Waste Risk Score: 50 / 10
Warning Flags
- Potential for price increases if competition is limited in future solicitations.
- Supply chain disruptions could impact reagent availability.
Positive Signals
- Contract supports a critical healthcare need.
- Utilizes a competed process for acquisition.
Sector Analysis
The healthcare sector, particularly in-vitro diagnostics, is crucial for patient care and disease management. Spending benchmarks for such supplies can vary significantly based on product type, volume, and supplier.
Small Business Impact
Analysis of small business participation is not directly available from the provided data. Further investigation would be needed to determine if small businesses were involved in the subcontracting or prime contracting.
Oversight & Accountability
The Department of Veterans Affairs is responsible for oversight of this contract. Standard procurement regulations and contract management practices should ensure accountability and performance.
Related Government Programs
- In-Vitro Diagnostic Substance Manufacturing
- Department of Veterans Affairs Contracting
- Department of Veterans Affairs Programs
Risk Flags
- Reliance on a single supplier.
- Potential for supply chain disruptions.
- Need for ongoing price competitiveness analysis.
- Limited visibility into specific product mix and quantities.
Tags
in-vitro-diagnostic-substance-manufactur, department-of-veterans-affairs, nm, purchase-order, under-100k
Frequently Asked Questions
What is this federal contract paying for?
Department of Veterans Affairs awarded $40,791.96 to QUIDELORTHO SALES COMPANY, LLC. QUIDELORTHRO TRIAGE METERPRO REAGENTS AND SUPPLIES
Who is the contractor on this award?
The obligated recipient is QUIDELORTHO SALES COMPANY, LLC.
Which agency awarded this contract?
Awarding agency: Department of Veterans Affairs (Department of Veterans Affairs).
What is the total obligated amount?
The obligated amount is $40,791.96.
What is the period of performance?
Start: 2025-02-13. End: 2026-02-12.
What is the specific breakdown of reagent types and quantities included in this contract?
The provided data does not detail the specific types or quantities of QuidelOrtho Triage MeterPro reagents and supplies. A comprehensive understanding of value would require a detailed list of items, their specifications, and the quantities ordered to assess if the $40.8M award is justified based on market rates for each component.
Are there any single points of failure in the supply chain for these critical reagents?
While the contract is with QuidelOrtho Sales Company, LLC, the risk of single points of failure in the supply chain is inherent. Dependence on a single manufacturer for specialized reagents can create vulnerabilities. Mitigation strategies, such as maintaining safety stock and exploring alternative suppliers for future contracts, are crucial.
How does the pricing compare to commercial healthcare providers for similar reagent volumes?
Direct comparison to commercial pricing is challenging without specific volume and product details. However, the 'COMPETED UNDER SAP' designation suggests an effort to achieve fair and reasonable pricing. A formal price analysis against commercial benchmarks or other federal contracts would be necessary for a definitive assessment.
Industry Classification
NAICS: Manufacturing › Pharmaceutical and Medicine Manufacturing › In-Vitro Diagnostic Substance Manufacturing
Product/Service Code: MEDICAL/DENTAL/VETERINARY EQPT/SUPP
Competition & Pricing
Extent Competed: COMPETED UNDER SAP
Solicitation Procedures: SIMPLIFIED ACQUISITION
Solicitation ID: 36C26225Q0437
Offers Received: 6
Pricing Type: FIRM FIXED PRICE (J)
Evaluated Preference: NONE
Contractor Details
Address: 9975 SUMMERS RIDGE RD, SAN DIEGO, CA, 92121
Business Categories: Category Business, Corporate Entity Not Tax Exempt, Limited Liability Corporation, Small Business, Special Designations, U.S.-Owned Business
Financial Breakdown
Contract Ceiling: $40,792
Exercised Options: $40,792
Current Obligation: $40,792
Contract Characteristics
Commercial Item: COMMERCIAL PRODUCTS/SERVICES
Timeline
Start Date: 2025-02-13
Current End Date: 2026-02-12
Potential End Date: 2026-02-12 00:00:00
Last Modified: 2026-04-09
More Contracts from Quidelortho Sales Company, LLC
- Lease of Ortho Vision and Reagents — $838.5K (Department of Veterans Affairs)
- ::blood Bank Analyzer:: — $172.7K (Department of Veterans Affairs)
- Blood Bank Testing Quality Control for Boise VA Medical Center — $66.1K (Department of Veterans Affairs)
- Blook Bank Testing Supplies — $45.2K (Department of Veterans Affairs)
- Ortho Clinical BPA Call Against 75H70621A00009; Srsu/Fyh — $33.0K (Department of Health and Human Services)
Other Department of Veterans Affairs Contracts
- CCN Region 3 Express Report — $5.2B (Optum Public Sector Solutions, Inc.)
- Express Report for FY22 Region 2 — $5.1B (Optum Public Sector Solutions, Inc.)
- Fiscal Year 2022 Express Report for Region 1 — $4.2B (Optum Public Sector Solutions, Inc.)
- Express Report for the Patient Centered Community Care (PC3) Contract — $3.3B (Triwest Healthcare Alliance Corp)
- CCN Region Three FY21 Express Report — $3.1B (Optum Public Sector Solutions, Inc.)